The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties. ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose:
Latest NewsMarch 21, 2023 Walgreens comprises about 10% of the retail pharmacy market in California, and is a 17% owner of AmerisourceBergen Drug Corp., which provided about $52 million worth of drugs for state agencies in 2022. About 80% of Medi-Cal patients live within 5 miles of a Walgreens outlet, and Blue Shield of California is a Medi-Cal provider that contracts with Walgreens for pharmaceutical benefits. What would “disentanglement” mean for access to prescriptions for Medi-Cal patients? Would patients with diabetes be prevented from using Walgreens as their source of California’s generic insulin? Walgreens also has relationships with the School of Pharmacy at UCSF, where it participates in the faculty’s research into health outcomes related to HIV and specialty pharmacy services, vaccinations, access to care, adherence and clinical outcomes, digital health and member engagement, and health care costs. Walgreens also collaborates with the Scripps Translational Science Institute – will Newsom’s pledge affect these relationships? Of course, as the author notes, discontinuation could adversely affect Walgreens’ earnings, and cause significant financial harm. Not considered by the author, however, is the cost to the state if the decision results in significant litigation. [Evans VB. What will California Gov. Gavin Newsom give up by cutting ties with Walgreens? AHLA Bulletin, 2023 Mar 16; https://bit.ly/3yXd8N6]
|